BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8389524)

  • 1. Multivariate analysis of magnetic resonance imaging of focal hepatic lesions.
    Fujishima M; Suemitsu I; Sei T; Takeda Y; Hiraki Y
    Acta Med Okayama; 1993 Apr; 47(2):117-20. PubMed ID: 8389524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.
    Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM
    AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases.
    Quan XY; Sun XJ; Yu ZJ; Tang M
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):406-9. PubMed ID: 16109526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis by MRT of cavernous hemangiomas and malignant tumors of the liver--advantages of the multi-echo technic].
    Koch M; Lüning M; Mühler A; Simon C
    Radiol Diagn (Berl); 1990; 31(2):127-34. PubMed ID: 2160668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MRI imaging of liver neoplasma].
    Mio A; Suzuki T; Suzaki K
    Rinsho Hoshasen; 1989 Dec; 34(13):1579-84. PubMed ID: 2560082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal hepatic lesions: differentiation with MR imaging at 0.5 T.
    Brown JJ; Lee JM; Lee JK; Van Lom KJ; Malchow SC
    Radiology; 1991 Jun; 179(3):675-9. PubMed ID: 2027973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
    Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
    AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
    Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
    Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P; Dufresne AC; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic tumors: quantitative tissue characterization with MR imaging.
    Egglin TK; Rummeny E; Stark DD; Wittenberg J; Saini S; Ferrucci JT
    Radiology; 1990 Jul; 176(1):107-10. PubMed ID: 2162067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma.
    Yu JS; Kim KW; Park MS; Yoon SW
    J Comput Assist Tomogr; 2002; 26(3):411-7. PubMed ID: 12016371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging (MRI) in 100 cases of mass lesions in the liver.
    Meng T; Su XZ
    Chin Med J (Engl); 1990 Aug; 103(8):673-9. PubMed ID: 2173656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
    Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
    Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
    Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
    AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.